JP2022533968A5 - - Google Patents
Info
- Publication number
- JP2022533968A5 JP2022533968A5 JP2021568431A JP2021568431A JP2022533968A5 JP 2022533968 A5 JP2022533968 A5 JP 2022533968A5 JP 2021568431 A JP2021568431 A JP 2021568431A JP 2021568431 A JP2021568431 A JP 2021568431A JP 2022533968 A5 JP2022533968 A5 JP 2022533968A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- approximately
- compound
- daily dose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025118412A JP2025165957A (ja) | 2019-05-23 | 2025-07-14 | ブルトン型チロシンキナーゼ阻害剤を使用したシェーグレン症候群を処置する方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962851994P | 2019-05-23 | 2019-05-23 | |
| US62/851,994 | 2019-05-23 | ||
| PCT/IB2020/054754 WO2020234781A1 (en) | 2019-05-23 | 2020-05-20 | Methods of treating sjögren's syndrome using a bruton's tyrosine kinase inhibitor |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025118412A Division JP2025165957A (ja) | 2019-05-23 | 2025-07-14 | ブルトン型チロシンキナーゼ阻害剤を使用したシェーグレン症候群を処置する方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022533968A JP2022533968A (ja) | 2022-07-27 |
| JP2022533968A5 true JP2022533968A5 (https=) | 2023-05-29 |
| JP7765970B2 JP7765970B2 (ja) | 2025-11-07 |
Family
ID=70918750
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021568431A Active JP7765970B2 (ja) | 2019-05-23 | 2020-05-20 | ブルトン型チロシンキナーゼ阻害剤を使用したシェーグレン症候群を処置する方法 |
| JP2025118412A Pending JP2025165957A (ja) | 2019-05-23 | 2025-07-14 | ブルトン型チロシンキナーゼ阻害剤を使用したシェーグレン症候群を処置する方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025118412A Pending JP2025165957A (ja) | 2019-05-23 | 2025-07-14 | ブルトン型チロシンキナーゼ阻害剤を使用したシェーグレン症候群を処置する方法 |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US12383556B2 (https=) |
| EP (2) | EP3972603B1 (https=) |
| JP (2) | JP7765970B2 (https=) |
| KR (1) | KR20220011652A (https=) |
| CN (1) | CN113811301A (https=) |
| AU (2) | AU2020278236C1 (https=) |
| BR (1) | BR112021023110A2 (https=) |
| CA (1) | CA3137271A1 (https=) |
| CL (1) | CL2021003034A1 (https=) |
| DK (1) | DK3972603T3 (https=) |
| ES (1) | ES3004516T3 (https=) |
| FI (1) | FI3972603T3 (https=) |
| HR (1) | HRP20241584T1 (https=) |
| HU (1) | HUE069020T2 (https=) |
| IL (1) | IL287745B2 (https=) |
| LT (1) | LT3972603T (https=) |
| MX (1) | MX2021014161A (https=) |
| PL (1) | PL3972603T3 (https=) |
| PT (1) | PT3972603T (https=) |
| RS (1) | RS66195B1 (https=) |
| SI (1) | SI3972603T1 (https=) |
| TW (1) | TWI857060B (https=) |
| WO (1) | WO2020234781A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112021023110A2 (pt) | 2019-05-23 | 2022-04-12 | Novartis Ag | Métodos de tratamento de síndrome de sjögren com o uso de um inibidor de tirosina quinase de bruton |
| MX2023008671A (es) * | 2021-01-26 | 2023-09-25 | Novartis Ag | Composicion farmaceutica. |
| CN116782888A (zh) * | 2021-01-26 | 2023-09-19 | 诺华股份有限公司 | 药物组合物 |
| JP7564347B2 (ja) | 2021-09-03 | 2024-10-08 | ノバルティス アーゲー | 多発性硬化症を治療するためのｌｏｕ０６４ |
| US20250032488A1 (en) | 2021-12-14 | 2025-01-30 | Novartis Ag | Methods of treatment using lou064 |
| TW202342048A (zh) | 2022-02-28 | 2023-11-01 | 瑞士商諾華公司 | 使用ｌｏｕ０６４治療化膿性汗腺炎之方法 |
| KR102875105B1 (ko) | 2023-04-03 | 2025-10-21 | 주식회사 사이알바이오 | 재조합 세마포린 4d 차단항체를 유효성분으로 포함하는 쇼그렌 증후군 예방 또는 치료용 약학 조성물 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ532310A (en) | 2001-10-05 | 2007-02-23 | Combinatorx Inc | Combinations comprising a tetra-substituted pyrimidopyrimidine and a corticosteroid for the treatment of immunoinflammatory disorders |
| US9512084B2 (en) | 2013-11-29 | 2016-12-06 | Novartis Ag | Amino pyrimidine derivatives |
| LT3390390T (lt) | 2015-12-16 | 2021-11-25 | Boehringer Ingelheim International Gmbh | Bipirazolilo dariniai, tinkami naudoti autoimuninių ligų gydymui |
| US10570118B2 (en) | 2016-01-13 | 2020-02-25 | Boehringer Ingelheim International Gmbh | Isoquinolones as BTK inhibitors |
| US10874741B2 (en) | 2017-08-28 | 2020-12-29 | Spectrix Therapeutics, LLC | Compound to treat Sjogren's syndrome |
| KR20200074993A (ko) | 2017-11-03 | 2020-06-25 | 노파르티스 아게 | 쇼그렌 증후군 치료에 사용하기 위한 항-cd40 항체 |
| TWI694995B (zh) * | 2017-11-06 | 2020-06-01 | 美商美國禮來大藥廠 | Btk抑制劑化合物 |
| BR112021023110A2 (pt) | 2019-05-23 | 2022-04-12 | Novartis Ag | Métodos de tratamento de síndrome de sjögren com o uso de um inibidor de tirosina quinase de bruton |
-
2020
- 2020-05-20 BR BR112021023110A patent/BR112021023110A2/pt unknown
- 2020-05-20 WO PCT/IB2020/054754 patent/WO2020234781A1/en not_active Ceased
- 2020-05-20 HR HRP20241584TT patent/HRP20241584T1/hr unknown
- 2020-05-20 CN CN202080032174.XA patent/CN113811301A/zh active Pending
- 2020-05-20 RS RS20241280A patent/RS66195B1/sr unknown
- 2020-05-20 US US17/612,737 patent/US12383556B2/en active Active
- 2020-05-20 SI SI202030536T patent/SI3972603T1/sl unknown
- 2020-05-20 CA CA3137271A patent/CA3137271A1/en active Pending
- 2020-05-20 FI FIEP20729203.8T patent/FI3972603T3/fi active
- 2020-05-20 HU HUE20729203A patent/HUE069020T2/hu unknown
- 2020-05-20 DK DK20729203.8T patent/DK3972603T3/da active
- 2020-05-20 LT LTEPPCT/IB2020/054754T patent/LT3972603T/lt unknown
- 2020-05-20 EP EP20729203.8A patent/EP3972603B1/en active Active
- 2020-05-20 ES ES20729203T patent/ES3004516T3/es active Active
- 2020-05-20 MX MX2021014161A patent/MX2021014161A/es unknown
- 2020-05-20 JP JP2021568431A patent/JP7765970B2/ja active Active
- 2020-05-20 PT PT207292038T patent/PT3972603T/pt unknown
- 2020-05-20 AU AU2020278236A patent/AU2020278236C1/en active Active
- 2020-05-20 IL IL287745A patent/IL287745B2/en unknown
- 2020-05-20 PL PL20729203.8T patent/PL3972603T3/pl unknown
- 2020-05-20 KR KR1020217039591A patent/KR20220011652A/ko active Pending
- 2020-05-20 EP EP24191253.4A patent/EP4442321A3/en active Pending
- 2020-05-21 TW TW109116855A patent/TWI857060B/zh active
-
2021
- 2021-11-17 CL CL2021003034A patent/CL2021003034A1/es unknown
-
2025
- 2025-07-14 JP JP2025118412A patent/JP2025165957A/ja active Pending
- 2025-07-14 US US19/268,023 patent/US20250339428A1/en active Pending
- 2025-11-06 AU AU2025263830A patent/AU2025263830A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022533968A5 (https=) | ||
| JP7650929B2 (ja) | 成人における焦点てんかんの処置のための合成経皮的カンナビジオール | |
| Kovanecz et al. | Long-term continuous sildenafil treatment ameliorates corporal veno-occlusive dysfunction (CVOD) induced by cavernosal nerve resection in rats | |
| TWI250016B (en) | Use of pramipexole for the treatment of addictive disorders | |
| JP2505944B2 (ja) | （Ｓ）―α―フルオロメチル―ヒスチジン及びそのエステルを含有するぜん息治療用医薬組成物 | |
| Sanchez et al. | Treatment of cerebral aspergillosis with itraconazole: do high doses improve the prognosis? | |
| JP2024540183A5 (https=) | ||
| HUE029677T2 (hu) | Készítmények centrálisan mediált émelygés és hányás kezelésére | |
| JP2024515829A5 (https=) | ||
| JP2021502392A5 (https=) | ||
| JP2009544585A5 (https=) | ||
| JP2020535161A5 (https=) | ||
| EP4494701A3 (en) | New therapeutic combinations for the treatment of progressive fibrosing interstitial lung diseases | |
| JP2022533981A5 (https=) | ||
| AU2014249530B2 (en) | Use of levocetirizine and montelukast in the treatment of anaphylaxis | |
| JP2019513814A5 (https=) | ||
| JPWO2023054732A5 (https=) | ||
| CN109316480A (zh) | 组合als疗法 | |
| JP2023509698A5 (https=) | ||
| JP2024523559A5 (https=) | ||
| JP2023549849A5 (https=) | ||
| JP2019507786A5 (https=) | ||
| JP2022514561A5 (https=) | ||
| JP2006515361A (ja) | ヘルペスウイルス感染の症候を治療又は予防する方法 | |
| JP2023531930A5 (https=) |